These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7023224)

  • 41. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias.
    Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1979 Aug; 91(2):229-38. PubMed ID: 380436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation.
    Chow MS; Kluger J; Lawrence R; Fieldman A
    Proc Soc Exp Biol Med; 1986 May; 182(1):63-7. PubMed ID: 3083422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bretylium in hypothermia-induced ventricular fibrillation in dogs.
    Elenbaas RM; Mattson K; Cole H; Steele M; Ryan J; Robinson W
    Ann Emerg Med; 1984 Nov; 13(11):994-9. PubMed ID: 6486552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implantable pharmacological defibrillator (AIPhD): preliminary investigations in animals.
    Cammilli L; Mugelli A; Grassi G; Alcidi L; Melissano G; Menegazzo G; Silvestri V
    Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):381-6. PubMed ID: 1706857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of quinidine and bretylium on defibrillation energy requirements.
    Dorian P; Fain ES; Davy JM; Winkle RA
    Am Heart J; 1986 Jul; 112(1):19-25. PubMed ID: 3728282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E; Gibson JK
    Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bretylium tosylate in patients with acute myocardial infarction.
    Torresani J
    Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antifibrillatory effects of high dose bretylium and a lidocaine-bretylium combination during cardiopulmonary resuscitation.
    Hanyok JJ; Chow MS; Kluger J; Fieldman A
    Crit Care Med; 1988 Jul; 16(7):691-4. PubMed ID: 3131067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quinidine syncope. A report of successful treatment with bretylium tosylate.
    VanderArk CR; Reynolds EW; Kahn DR; Tullett G
    J Thorac Cardiovasc Surg; 1976 Sep; 72(3):464-7. PubMed ID: 957762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Life threatening ventricular dysrhythmias: intervention with bretylium tosylate.
    Sullivan HE; Wehner RJ
    AANA J; 1983 Jun; 51(3):284-9. PubMed ID: 6613506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent ventricular fibrillation treated with countershocks, bretylium tosylate, and rapid cardiac pacing.
    Joshpe G; Topilow A; Levitt B; Grishman A; Schwimmer J
    N Y State J Med; 1972 Nov; 72(21):2659-63. PubMed ID: 4508269
    [No Abstract]   [Full Text] [Related]  

  • 52. Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases.
    Anderson JL; Popat KD; Pitt B
    Arch Intern Med; 1981 May; 141(6):801-2. PubMed ID: 7235792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical experiences with bretylium tosylate].
    Steffen V; Assmann I; Fiehring H
    Z Gesamte Inn Med; 1976 Sep; 31(17):684-8. PubMed ID: 793213
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bretylium tosylate in the management of refractory ventricular fibrillation.
    Dhurandhar RW; Teasdale SJ; Mahon WA
    Can Med Assoc J; 1971 Jul; 105(2):161-5 passim. PubMed ID: 5556280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
    Holland K; Patterson E; Lucchesi BR
    Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: clinical application of a new assay for bretylium.
    Anderson JL; Patterson E; Wagner JG; Johnson TA; Lucchesi BR; Pitt B
    J Cardiovasc Pharmacol; 1981; 3(3):485-99. PubMed ID: 6168830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Massive intravenous bolus bretylium tosylate.
    Bodnar T; Nowak R; Tomlanovich MC
    Ann Emerg Med; 1980 Dec; 9(12):630-3. PubMed ID: 7447102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study.
    Koo CC; Allen JD; Pantridge JF
    Cardiovasc Res; 1984 Dec; 18(12):762-7. PubMed ID: 6518459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac arrhythmias. 6. Ventricular tachyarrhythmias. Clinical aspects.
    Lown B; Temte JV; Arter WJ
    Circulation; 1973 Jun; 47(6):1364-81. PubMed ID: 4709549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.